Biopsy-based single-cell transcriptomics reveals MAIT cells as potential targets for controlling fibrosis-related liver inflammation due to chronic hepatitis-B infection
Clin Transl Med
.
2022 Oct;12(10):e1073.
doi: 10.1002/ctm2.1073.
Authors
Li Shao
1
,
Hong Zhao
2
,
Rongfang Guo
3
,
Jinlin Cheng
2
,
Xiaoyan Lu
3
,
Xiaohui Fan
3
4
5
Affiliations
1
School of Clinical Medicine, Hangzhou Normal University, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
2
The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
3
Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
4
Innovation Center in Zhejiang University, State Key Laboratory of Component-Based Chinese Medicine, Hangzhou, China.
5
Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
PMID:
36263680
PMCID:
PMC9582669
DOI:
10.1002/ctm2.1073
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Biopsy
Fibrosis
Hepatitis B, Chronic*
Humans
Inflammation / genetics
Liver Cirrhosis / genetics
Mucosal-Associated Invariant T Cells*
Transcriptome / genetics